Diabetes Type 1 and Type 2—a Study on Country-wise Disease Demographics

The pervasiveness of diabetes type 1 and type 2 has had a notable impact on people's well-being and hampered the healthcare system's sustainability. A study forecasts that around 783.7 million people will live with diabetes by 2045. Strain diabetes puts on the economy and the complications linked to the disease have warranted a holistic approach to develop strategies to minimize prevalence and foster healthcare. There is a general acceptance that physical activity and healthy food habits could reduce obesity rates and diabetes risks. 

Researchers, manufacturers and other stakeholders are navigating growth and opportunities in diabetes devices and treatment. The development of advanced treatment options could be pronounced amid the aging population. A healthy lifestyle and better diabetes medications are expected to make a difference in minimizing diabetes. The final report, coupled with the database, will deep-dive into the following dynamics:

• Decision-making process and customer buying pattern.

• Reimbursement landscape and diabetes-related expenditure per person.

• Treatment options and related costs across countries.

• Comparative prevalence of diabetes.

Get your copy or request a free sample of the report “Disease Demographics for Diabetes Type 1 and Type 2, 2023,” compiled and published by Grand View Research. 

Disease Demographics for Diabetes Type 1 and Type 2 Report Scope

Attribute	Details
Patient Demographics	Total Population People with diabetes People with undiagnosed diabetes Deaths attributable to diabetes
Treatment Options	Type 1 Diabetes Insulin Diet Blood glucose monitoring Type 2 Diabetes Oral Medications Diet Exercise Blood glucose monitoring Insulin
Treatment Cost Per Patient	Total diabetes-related health expenditure, USD Million Diabetes-related health expenditure per person, USD
Quality of Life	Disability-adjusted life years (DALYs)
Comorbidity Analysis	Diabetic foot ulcer Cardiovascular disease (CVD) Diabetic retinopathy Diabetic neuropathy Diabetic nephropathy
Reimbursement Differences	Coverage for Medicare and Medicaid Type 1 Diabetes Type 2 Diabetes
Regions	North America U.S. Canada Europe UK Germany France Italy Spain Denmark Sweden Norway Asia Pacific Japan China India Australia Thailand South Korea Latin America Brazil Mexico Argentina MEA South Africa Saudi Arabia UAE Kuwait

Related Reports:

• Diabetes Devices Market Size, Share & Trends Analysis Report By Type (BGM Devices, Insulin Delivery Devices), By Distribution Channel, By End Use (Hospitals, Homecare), By Region, And Segment Forecasts, 2022 - 2030

• Diabetes Associated Ophthalmic Treatment Market Size, Share & Trends Analysis Report By Type (Drugs, Devices), By Application (Dry Eye, Glaucoma, Diabetic Retinopathy, DAMD, Uveitis, Cataract), By End-use, By Region, And Segment Forecasts, 2021 - 2028

About Us

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.

Find More information @ https://www.grandviewresearch.com/info/trend-reports